We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GLTO market cap is 6.14M. The company's latest EPS is USD -29.1187 and P/E is -0.16.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.58M | -6.67M | -5.74M | -5.58M | -3.84M |
| Net Income | -8.14M | -6.48M | -5.48M | -5.34M | -3.88M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -38.97M | -33.64M | -52.23M | -61.21M | -39.91M |
| Net Income | -42.07M | -34.84M | -51.75M | -61.62M | -38.35M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 50.05M | 38.23M | 32.48M | 27.3M | 23.38M |
| Total Liabilities | 12.67M | 5.9M | 4.32M | 3.71M | 2.44M |
| Total Equity | 37.38M | 32.33M | 28.16M | 23.59M | 20.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 56.61M | 171.6M | 122.22M | 73.19M | 38.23M |
| Total Liabilities | 8.14M | 6.11M | 4.99M | 11.44M | 5.9M |
| Total Equity | -71.15M | 165.49M | 117.22M | 61.75M | 32.33M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.44M | -36.91M | -5.94M | -10.04M | -13.69M |
| Investing | 12.75M | 22.33M | 5.65M | 11.65M | 11.65M |
| Financing | 2.88M | 2.88M | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.33M | -38.2M | -52.31M | -42.93M | -36.91M |
| Investing | -326k | N/A | -48.05M | 12.38M | 22.33M |
| Financing | N/A | 187.39M | N/A | 507k | 2.88M |
| Market Cap | 6.14M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.29 |
| Price to Book Ratio | 0.19 |
| Dividend Yield | - |
| Shares Outstanding | 1.32M |
| Average Volume (1 week) | 20.23k |
| Average Volume (1 Month) | 21.59k |
| 52 Week Change | -71.76% |
| 52 Week High | 23.50 |
| 52 Week Low | 4.4006 |
| Spread (Intraday) | 0.3 (6.37%) |
| Company Name | Galecto Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.galecto.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
